Incyte today announced positive topline results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19 ...
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi ® (tafasitamab) in combination with rituximab and lenalidomide for adult ...
YouTube is the biggest video streaming service in the world, with the platform boasting more than 2.5 billion monthly active users. However, users are miffed because of multiple non-skippable ads on ...
† Department of Environmental Geosciences and Environmental Science Research Network, University of Vienna, Althanstrasse 14, UZA2, 1090 Vienna, Austria ‡ Institute of Environmental Biotechnology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback